Therapeutics Acquisition Corp. (RACA) Shareholders Approve POINT Biopharma Deal
Therapeutics Acquisition Corp. (NASDAQ:RACA) announced in an 8-K filing this morning that its shareholders approved its combination with radiopharmaceutical firm POINT Biopharma at a special meeting yesterday.
A not-insignificant number of shareholders opted to redeem their shares in connection with the vote, however.
...READ MORE